Anlotinib Inhibits Ovarian Cancer and Enhances Cisplatinum Sensitivity via Suppressing NOTCH2 Expression and Stemness
X Xu, Q Wang, L Shen, Y Shen, H Liu, Y Liu… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: The prognosis of ovarian cancer (OC) patients is especially poor for
patients with chemotherapy resistance. Anlotinib, a novel multi-targeted tyrosine kinase …
patients with chemotherapy resistance. Anlotinib, a novel multi-targeted tyrosine kinase …
Effective Treatment of Anlotinib Combined With Chemotherapy in Children With Desmoplastic Small Round Cell Tumor: A Case Series in a Single-center and …
XY Jing, CQ Shen, GQ He, RR Xu… - Journal of Pediatric …, 2024 - journals.lww.com
Effective Treatment of Anlotinib Combined With Chemotherapy... : Journal of Pediatric
Hematology/Oncology Effective Treatment of Anlotinib Combined With Chemotherapy in …
Hematology/Oncology Effective Treatment of Anlotinib Combined With Chemotherapy in …
A pilot study of Anlotinib as a combination treatment in advanced nasopharyngeal carcinoma
R Zhou, P Zhou, YF Yu, Q Lin… - Current Cancer Drug …, 2024 - ingentaconnect.com
Aims: To investigate the short-term objective response and treatment toxicity of anlotinib as a
combination treatment in patients with Recurrent or Metastatic Nasopharyngeal Carcinoma …
combination treatment in patients with Recurrent or Metastatic Nasopharyngeal Carcinoma …
The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report
W Deng, J Chen, XY Deng - Frontiers in Immunology, 2024 - frontiersin.org
Background Extensive-stage small-cell lung cancer (ES-SCLC) is highly malignant, with
early metastasis and high recurrence. Since therapeutic options are limited, ES-SCLC has a …
early metastasis and high recurrence. Since therapeutic options are limited, ES-SCLC has a …
Sustained response to anlotinib in advanced pancreatic neuroendocrine carcinoma: A case report
Y Zhang, Y Wang, J Wu, Z Zhong, J Li… - Oncology …, 2024 - spandidos-publications.com
Pancreatic neuroendocrine carcinoma (pNEC) is a type of pancreatic neuroendocrine
neoplasm with a poor prognosis, and patients with metastatic pNEC have a survival time of …
neoplasm with a poor prognosis, and patients with metastatic pNEC have a survival time of …
Anlotinib for Pulmonary Sarcomatoid Carcinoma
XY Ma, YJ Wang, DX Zeng - American Journal of Therapeutics, 2024 - journals.lww.com
To the editor: Sarcomatoid carcinoma (SC), comprising 0.1%-0.4% of all pulmonary
malignancies, is a rare malignancy with a combination of epithelial and sarcoma or sarcoma …
malignancies, is a rare malignancy with a combination of epithelial and sarcoma or sarcoma …